Pathologic complete response strongly correlates with outcomes — but is it enough to change practice?
This clip explores why regulators still require event-free survival data, how RCB scoring is being used, and why better biomarkers are urgently needed to guide escalation and de-escalation strategies.
Is pCR Enough? Why Regulators Still Want EFS Data
You may also like
Recommended Videos
